Filtered By:
Vaccination: Pneomococcal Vaccine

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 3041 results found since Jan 2013.

Reducing the risk of infections in hereditary and acquired complement deficiencies.
Orv Hetil. 2023 Jun 25;164(25):971-980. doi: 10.1556/650.2023.32798. Print 2023 Jun 25.ABSTRACTHereditary complement deficiencies are relatively rare worldwide, they account for about 1-10% of primary immunodeficiencies. Acquired complement deficiencies are more prevalent and with the more frequent use of complement inhibitor therapy, the incidence of patients with iatrogenic complement deficiency is increasing. Alike in the inherited forms, patients have a high risk of severe and life-threatening infections caused by encapsulated bacteria (sepsis, meningitis). The most frequent pathogens are Neisseria meningitidis, Strept...
Source: Orvosi Hetilap - June 25, 2023 Category: General Medicine Authors: Éva Karászi Be áta Onozó Andrea Kulcs ár J ános Szlávik Vera Goda Gergely Kriv án Zolt án Prohászka Botond Lakatos Source Type: research

The impact of implementing the 10-valent pneumococcal conjugate vaccine on hospitalizations for pneumonia among children
In conclusion, in the five years following implementation of PCV-10, hospitalizations of children with pneumonia in Pernambuco decrease by 22%.PMID:37353456 | DOI:10.1016/j.vaccine.2023.06.049
Source: Vaccine - June 23, 2023 Category: Allergy & Immunology Authors: Ana Catarina de Melo Araujo Jamilly da Silva Arag ão Wayner Vieira de Souza Laura Cunha Rodrigues Dem ócrito de Barros Miranda-Filho Source Type: research

Dynamics of invasive pneumococcal disease in infants & lt;  2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019
ConclusionsIndirect (herd) protection of infants, including < 4 month-olds with ≤ 1 PCV dose, was achieved by the 2+1 PCV schedule programme which thus seems adequate.PMID:37347413 | PMC:PMC10288828 | DOI:10.2807/1560-7917.ES.2023.28.25.2200765
Source: Euro Surveill - June 22, 2023 Category: Infectious Diseases Authors: Shalom Ben-Shimol Bart Adriaan van der Beek Meirav Mor Orli Megged Ron Dagan Israeli Pediatric Bacteremia and Meningitis Group (IPBMG) and the Microbiology Group Source Type: research

A novel immuno-molecular strategy for the detection of Streptococcus pneumoniae serotypes in human cerebrospinal and middle ear fluids
J Immunol Methods. 2023 Jun 20:113516. doi: 10.1016/j.jim.2023.113516. Online ahead of print.ABSTRACTStreptococcus pneumoniae is one of the most common microorganisms causing acute otitis media (AOM) in children. While bacterial culture of middle ear fluid (MEF) is the gold standard to detect the etiological organisms, several host and pathogen factors impact the survival of the organisms resulting in false negatives. To overcome this limitation, we have developed and validated an innovative multiplex immuno-molecular assay to screen and detect the S. pneumoniae 15-valent pneumococcal conjugate vaccine (PCV15; STs 1, 3, 4,...
Source: Journal of Immunological Methods - June 22, 2023 Category: Allergy & Immunology Authors: Gowrisankar Rajam Kate L Hicks Joseph M Antonello Yuhua Zhang Sarah Irey Julia Kelly Stephanie Cooper Leonard J Rubinstein Source Type: research

Dynamics of invasive pneumococcal disease in infants & lt;  2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019
ConclusionsIndirect (herd) protection of infants, including < 4 month-olds with ≤ 1 PCV dose, was achieved by the 2+1 PCV schedule programme which thus seems adequate.PMID:37347413 | PMC:PMC10288828 | DOI:10.2807/1560-7917.ES.2023.28.25.2200765
Source: Euro Surveill - June 22, 2023 Category: Infectious Diseases Authors: Shalom Ben-Shimol Bart Adriaan van der Beek Meirav Mor Orli Megged Ron Dagan Israeli Pediatric Bacteremia and Meningitis Group (IPBMG) and the Microbiology Group Source Type: research

A novel immuno-molecular strategy for the detection of Streptococcus pneumoniae serotypes in human cerebrospinal and middle ear fluids
J Immunol Methods. 2023 Jun 20:113516. doi: 10.1016/j.jim.2023.113516. Online ahead of print.ABSTRACTStreptococcus pneumoniae is one of the most common microorganisms causing acute otitis media (AOM) in children. While bacterial culture of middle ear fluid (MEF) is the gold standard to detect the etiological organisms, several host and pathogen factors impact the survival of the organisms resulting in false negatives. To overcome this limitation, we have developed and validated an innovative multiplex immuno-molecular assay to screen and detect the S. pneumoniae 15-valent pneumococcal conjugate vaccine (PCV15; STs 1, 3, 4,...
Source: Journal of Immunological Methods - June 22, 2023 Category: Allergy & Immunology Authors: Gowrisankar Rajam Kate L Hicks Joseph M Antonello Yuhua Zhang Sarah Irey Julia Kelly Stephanie Cooper Leonard J Rubinstein Source Type: research

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A phase III study (V114-033)
CONCLUSION: In Japanese infants, a four-dose series of V114 was generally well tolerated. Compared with PCV13, V114 provided non-inferior immune responses to the 13 shared serotypes and higher immune responses to serotype 22F and 33F post-primary series.TRIAL REGISTRATION: ClinicalTrials.gov: NCT04384107; EudraCT 2019-003644-68.PMID:37344262 | DOI:10.1016/j.vaccine.2023.05.064
Source: Vaccine - June 21, 2023 Category: Allergy & Immunology Authors: Hiroko Suzuki Hidetoshi Fujita Kazuyuki Iwai Haruo Kuroki Kazuhiko Taniyama Toshiyuki Shizuya Hiroyuki Kishino Rie Igarashi Masayoshi Shirakawa Miyuki Sawata Source Type: research

Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis
CONCLUSIONS: This review suggests that financial and social support, assertive communication, trust in political authorities and greater regulation of social media enhance adherence to prevention and control measures for COVID-19 and infectious respiratory diseases. Designing and implementing effective educational public health interventions targeting the findings of barriers and facilitators highlighted in this review are key to reducing the impact of infectious respiratory diseases at the population level.PMID:37343960 | DOI:10.1183/16000617.0238-2022
Source: Respiratory Care - June 21, 2023 Category: Respiratory Medicine Authors: T ácito Zaildo Thayla Amorim Santino Gabriela Chaves Baldomero Antonio Kato da Silva Jo ão Carlos Alchieri Cecilia M Patino Sarah Leite Kleber Giovanni Luz Ricardo Oliveira Guerra Tito Hugo Soares da Penha Gabriel Rodrigues da Silva Ada Cristina J ácom Source Type: research

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A phase III study (V114-033)
CONCLUSION: In Japanese infants, a four-dose series of V114 was generally well tolerated. Compared with PCV13, V114 provided non-inferior immune responses to the 13 shared serotypes and higher immune responses to serotype 22F and 33F post-primary series.TRIAL REGISTRATION: ClinicalTrials.gov: NCT04384107; EudraCT 2019-003644-68.PMID:37344262 | DOI:10.1016/j.vaccine.2023.05.064
Source: Vaccine - June 21, 2023 Category: Allergy & Immunology Authors: Hiroko Suzuki Hidetoshi Fujita Kazuyuki Iwai Haruo Kuroki Kazuhiko Taniyama Toshiyuki Shizuya Hiroyuki Kishino Rie Igarashi Masayoshi Shirakawa Miyuki Sawata Source Type: research

Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis
Conclusions: This review suggests that financial and social support, assertive communication, trust in political authorities and greater regulation of social media enhance adherence to prevention and control measures for COVID-19 and infectious respiratory diseases. Designing and implementing effective educational public health interventions targeting the findings of barriers and facilitators highlighted in this review are key to reducing the impact of infectious respiratory diseases at the population level.
Source: European Respiratory Review - June 21, 2023 Category: Respiratory Medicine Authors: Zaildo, T., Santino, T. A., Chaves, G., da Silva, B. A. K., Alchieri, J. C., Patino, C. M., Leite, S., Luz, K. G., Guerra, R. O., da Penha, T. H. S., da Silva, G. R., Jacome, A. C., Monteiro, K. S., de Mendonca, K. M. P. P. Tags: Respiratory infections and tuberculosis Reviews Source Type: research